Skip to content

NeoGenomics NEO Balance Sheet Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
$145.54M-5.9%$146.14M-57.8%$159.62M-56.5%$164.12M-54.7%$154.72M-56.4%
$175.41M+14.6%$167.42M+10.7%$159.24M+5.8%$155.3M+2.6%$153.13M+4.5%
$27.14M-20.6%$29.84M+0.2%$28.57M+6.8%$28.46M+16.4%$34.17M+47.2%
$381.48M-2.8%$373.68M-34.9%$376.29M-36.9%$382.47M-35.2%$392.55M-32.8%
$80.94M-5.3%$83.66M-6.6%$84.83M-9.8%$85.47M-8.1%$85.46M-7.3%
$524M0.0%$524M+0.2%$524.34M+0.3%$524.34M+0.3%$524.14M+0.3%
$257.82M-10.6%$265.45M-16.5%$286.53M-15.6%$280.72M-19.3%$288.35M-19.1%
$970.77M-3.1%$972.85M-5.3%$983.54M-5.6%$992.32M-5.6%$1B-5.4%
$1.35B-3.0%$1.35B-15.9%$1.36B-17.0%$1.37B-16.2%$1.39B-15.2%
$20.95M-23.8%$25.9M+59.8%$23.09M+6.9%$22.61M+36.9%$27.49M+60.0%
$194K-82.1%$561K-51.8%$851K+108%$1.58M+168%$1.08M+11.5%
$1.7M$0-100%
$105.88M+5.8%$84.59M-69.8%$88.3M-70.7%$97.87M-67.0%$100.12M-65.5%
$374.24M$341.86M
$460.63M+4.7%$433.18M-0.1%$434.97M+0.1%$438.62M+0.5%$439.79M+0.5%
$566.51M+4.9%$517.77M-27.4%$523.27M-28.9%$536.49M-26.8%$539.91M-25.8%
$130K+1.6%$129K+0.8%$129K+0.8%$128K0.0%$128K0.0%
-$448.67M-13.1%-$450.91M-28.2%-$433.81M-33.2%-$423.93M-36.5%-$396.8M-35.5%
$785.73M-8.0%$828.76M-6.7%$836.56M-7.3%$838.29M-7.7%$854.04M-6.8%
$1.35B-3.0%$1.35B-15.9%$1.36B-17.0%$1.37B-16.2%$1.39B-15.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are NeoGenomics's total assets?
NeoGenomics (NEO) holds $1.4B in total assets, down 3.0% year over year.
How much debt does NeoGenomics have?
NeoGenomics carries $448.4M in total debt against $785.7M of shareholders' equity, a debt-to-equity ratio of 0.57.
How much cash does NeoGenomics have?
NeoGenomics holds $145.5M in cash and equivalents.
Can NeoGenomics cover its short-term obligations?
Its current ratio is 3.60 — current assets exceed current liabilities.
Where does NeoGenomics's balance sheet data come from?
Every line is extracted from NeoGenomics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.